Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Current Topics in Microbiology and Immunology|December 15, 2012
Structure-based drug discovery for botulinum neurotoxinsSubramanyam SwaminathanThe FEBS Journal|May 20, 2011
Molecular structures and functional relationships in clostridial neurotoxinsSubramanyam SwaminathanThe Journal of Biological Chemistry|July 29, 2008
SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin ERakhi Agarwal, Subramanyam SwaminathanCurrent Topics in Medicinal Chemistry|March 10, 2015
Recent developments with metalloprotease inhibitor class of drug candidates for botulinum neurotoxinsGyanendra Kumar, Subramanyam SwaminathanMovement Disorders : Official Journal of the Movement Disorder Society|March 18, 2004
Structure and enzymatic activity of botulinum neurotoxinsSubramanyam Swaminathan, Subramanian Eswaramoorthy, Desigan KumaranBiochemistry|September 1, 2005
Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor designRakhi Agarwal, Thomas Binz, Subramanyam SwaminathanBiochemistry|July 31, 2002
A novel mechanism for Clostridium botulinum neurotoxin inhibitionSubramaniam Eswaramoorthy, Desigan Kumaran, Subramanyam SwaminathanBiochemistry|June 9, 2005
Analysis of active site residues of botulinum neurotoxin E by mutational, functional, and structural studies: Glu335Gln is an apoenzymeRakhi Agarwal, Thomas Binz, Subramanyam SwaminathanChemical Communications (Cambridge, England)|January 26, 2012
Discovery of a fluorene class of compounds as inhibitors of botulinum neurotoxin serotype E by virtual screeningGyanendra Kumar, Rakhi Agarwal, Subramanyam SwaminathanBioorganic & Medicinal Chemistry|June 30, 2016
Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure-activity relationship and a pharmacophore modelGyanendra Kumar, Rakhi Agarwal, Subramanyam SwaminathanPageof 7